⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CNSP News
CNS Pharmaceuticals, Inc. Common Stock
Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations | DelveInsight
globenewswire.com
ADAG
ABBV
BIIB
BMRN
BLRX
CNSP
CYCN
GEN
GILD
GRAF
GSK
HSIC
HUBS
IBIO
INCY
JAZZ
JNJ
MAGN
MARA
MRK
NVS
OMER
PFE
PRGS
REGN
RGNX
SRPT
TENB
TGLS
TGTX
TNDM
TXG
VRTX
Form 8-K
sec.gov
CNSP
CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing
accessnewswire.com
CNSP
Form 8-K
sec.gov
CNSP
CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline
accessnewswire.com
CNSP
Form 8-K
sec.gov
CNSP
CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team
accessnewswire.com
CNSP
CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation
accessnewswire.com
CNSP
CNS Pharmaceuticals Issues Letter to Shareholders
accessnewswire.com
CNSP
CNS Pharmaceuticals Announces CEO Transition
accessnewswire.com
CNSP